Article Listing - Stock Commentary - New York week to Aug 7, 2006

NIGERIAN HEALTH SPENDING FOR 1992

6 April 1992

The federal government of Nigeria has announced a total figure for health care spending in 1992 of 192 million naira,...

ARES-SERONO GAINS RIGHTS TO CUROSURF

6 April 1992

Swiss pharmaceutical group Ares-Serono has acquired exclusive marketing rights in most European territories for a natural pulmonary surfactant product, Curosurf,...

CHIROS ACQUIRES ENZYMATIX' CHIRAL DIV

6 April 1992

A new UK company, Chiros Ltd, was formed last month to purchase the assets and business of the Chiral division...

APPOINTMENTS AT AKZO

6 April 1992

Akzo NV of the Netherlands has appointed Lodewijk van Wachem and Abraham Cohen as members of its supervisory board.

PA CONSULTING GROUP APPOINTMENTS

6 April 1992

Appointed as senior associates for the pharmaceutical industry at PA Consulting Group are Keith Mansford, former chairman of R&D...

PHARMA COs TOP R&D SPEND IN JAPAN

6 April 1992

Of 16 Japanese companies planning to spend over 10% of their sales on R&D in 1992, nine are pharmaceutical companies,...

FURTHER FALLS FOR DEPRENYL?

6 April 1992

Shares of the Canadian biopharmaceutical company Deprenyl Re-search have recently lost value and could well fall further, according to local...

US HOSPITAL FORMULARY GUIDE

6 April 1992

The American Society of Hospital Pharmacists has released guidelines on formulary system management for its members.

The ASHP notes that in...

GALLUP SURVEYS UK GPs ON HEPATITIS A

6 April 1992

With the recent introduction of its hepatitis A vaccine Havrix to the UK market, SmithKline Beecham has sponsored a Gallup...

GENENTECH REBUFFS ISIS-3 AND AWAITS GUSTO

6 April 1992

With the formal publication in The Lancet last week of the results of the ISIS-3 thrombolytic product trial, the major...